2025 International Congress Archives

Early Impairment in the Immunomodulatory Function of Mesenchymal Stromal Cells Contributes to Heightened Peripheral and Neuroinflammation in Parkinson’s Disease Insights From In Vivo Chronic PD Rat Model and In Vitro PD iPSC Model

R. Ghanty, I. Datta, G. Wagmare, N. Kamble, PK. Pal, V. Holla, R. Yadav, K. Mondal (Bengaluru, India)
Early Indicators of Alpha-synuclein Aggregation: Can Autonomic and Cognitive Markers Predict Prodromal Parkinson’s Disease?

B. Kansu, C. Mattjie, R. Ravazio, M. Patyjewicz, A. Noyce, C. Simonet (London, United Kingdom)
Early Introduction of COMT Inhibitors at Low Levodopa Doses Improves Long-Term Motor Complications in Parkinson’s Disease: A sub-analysis of the REONPARK Study

J. García-Caldentey, D. Vilas Roldán, L. López-Manzanares, H. Brigas, D. Martins, J. Reis, J. Blanco Ameijeiras, M. Rodríguez-de Miguel, I. Tegel Ayuela (Palma de Mallorca, Spain)
Early-onset levodopa-responsive parkinsonism with cognitive impairment and head-bobbing dyskinesias associated with SYNJ1 and GBA variants of unknown significance

S. Rodrigo, M. Rosenbaum, J. Fleisher (Chicago, USA)
Early-Onset Parkinson’s Disease in Active-Duty Service Members

V. Nguyen, J. Jacobson, C. Hernandez-Zegada, M. Salas, W. Hoffman (San Antonio, USA)
Ecologically Valid, Ambient, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Parkinson’s Disease (EVALUATE-PD)

J. Kaye, E. Leonard, L. Talman, N. Rodrigues, Z. Beattie (Portland, USA)
Educational Innovation of Cerebellum and Ataxia Curriculum for Neurology Residents

Z. Xu, T. Milligan, S. Parauda, F. Danisi (New York, USA)
Educational Strategies for Enhancing Caregiver Knowledge and Capacities in Parkinson’s Disease Management: A Comprehensive Review

S. A. Hassan, S. Abozeid, Y. M.HUSSEINY, H. Abdelbar, S. Elrobeigi, M. M. Elsayed (Giza, Egypt)
EEG connectivity in Parkinson disease: a comparative analysis of sporadic and genetic forms in ON/OFF therapy.

M. Treddenti, V. Yahya, S. Marceglia, V. D'Onofrio, A. Guerra, T. Bocci, A. Priori (Milan, Italy)
EEG Correlates of Orthostatic Hypotension in Parkinson’s Disease: Novel Biomarkers for Autonomic Failure

A. Frohlich, J. Riddle, F. Frohlich, D. Rubinow, E. Dayan, M. Sklerov (Chapel Hill, USA)
Effect of Allogeneic Bone-Marrow Derived Mesenchymal Stem Cell Therapy on Quality of Life in Patients with Parkinson’s Disease

C. Onuigbo, J. Martinez-Lemus, T. Thomas, E. Tharp, J. Suescun, C. Green, T. Ellmore, E. Rodarte Rascon, R. Ritter, M. Schiess (Houston, USA)
Effect of Antihypertensive Agent Choice on Parkinson’s Disease Progression in Patients with Hypertension

R. Gologorsky, A. Zolin, H. Ooi, H. Sarva (New York, USA)
Effect of Aβ on α-synuclein propagation

Y. Narumiya, E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, T. Maki, T. Saito, R. Takahashi, R. Matsumoto, H. Yamakado (Nagoya, Japan)
Effect of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa on motor fluctuations, dyskinesia, and sleep; subjective vs. PKG watch recordings.

M. Bradley, E. Donlon, A. Gallagher, C. O'Keefe, J. Inocentes, F. Ruggieri, R. Reilly, R. Walsh, T. Lynch, C. Fearon (Dublin, Ireland)
Effect of COVID-19 Pandemic on Utilization of Parkinson’s Medications in Saudi Arabia: A Repeated Cross-Sectional Study

K. Orayj (Abha, Saudi Arabia)
Effect of CUE1+ Device on Motor and Non-Motor Symptoms in Parkinson’s: A Pilot Randomised Controlled Trial.

V. Azoidou, K. Rowsell, E. Camboe, K. Dey, A. Zirra, C. Quah, T. Boyle, C. Budu, D. Gallagher, A. Noyce, C. Simonet (London, United Kingdom)
Effect of Exenatide on disease progression in early Parkinson’s disease–a randomized, placebo controlled, single-center trial in Sweden

I. Markaki, CC. Tang, PE. Papathoma, L. Hainke, W. Paslawski, J. Paslawska, I. Savitcheva, U. Estenberg, D. Eidelberg, P. Svenningsson (Solna, Sweden)
Effect of Exercise Intervention on Parkinson’s Disease Resting-State fMRI Functional Connectivity

E. Reimers, C. Bevington, J. Mckenzie, S. Dhaliwal, J. Stoessl, V. Sossi (Vancouver, Canada)
Effect of Long-Term Deep Brain Stimulation in BLC11B-related Dystonia

M. Skorvanek, V. Han, V. Magocova, A. Kollova, K. Knorovsky, M. Ostrozovicova, T. Svorenova, M. Zech (Košice, Slovakia)
Effect of Opicapone on Sleep-Related Complaints and Non-Motor Burden in Parkinson’s Patients: A Post-Hoc Analysis of the OASIS Trial

J. Ferreira, M. Gago, R. Costa, M. Fonseca, H. Brigas, D. Martins, J. Holenz, C. Trenkwalder (Lisbon, Portugal)
Effect of Patient Education Interventions on Non-Motor Symptoms and Disease Outcomes in Parkinson’s Disease: A systematic review

L. van Doeselaer, K. Colman, F. Dijkstra, D. Crosiers (Wilrijk, Belgium)
Effect of Reaction Oriented Training on Postural Stability and Reaction Time in Parkinsons’s Disease

M. Salamci, A. Guclu-Gunduz, C. Ozkul, R. Yılmaz, M. Akbostancı (Ankara, Turkey)
Effect of Sensory Feedback Vibration Stimulation Using an In-Sole Foot Pressure Monitor on Gait

K. Kakegawa, T. Matsuda, J. Ogawa, Y. Yamaguchi, K. Fujinawa (Bunkyo-ku, Tokyo, Japan)
Effect of Systematic Survey-based Screening for Depression in Parkinson’s Disease

M. Super, D. Potts, C. Marshall, N. Dahodwala (Philadelphia, USA)
Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

F. Luna-Rangel, B. Gonzalez-Bedolla, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)
Effectiveness and Outcomes of Deep Brain Stimulation revision surgery for Parkinson’s Disease

MG. Choi, SY. Jo, JH. Lee, SJ. Chung (Goyang-si, Republic of Korea)
Effectiveness of Intensive Speech Treatment for Friedreich’s Ataxia

L. Ramig, H. Hodges, E. Peterson, M. Tran, A. Lowit (Tucson, USA)
Effectiveness of Interactive Rhythmic Stimulation on Gait Improvement in Elderly Patients: An R and Python Perspective

N. Ali, Z. Hegazy, K. Ahmed, O. Sabry, S. Elsenbawy, G. Abozeid, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. Abouelseoud, H. Abdelbar, H. Khabiry, M. M. Elsayed (Mansoura, Egypt)
Effectiveness of Light Touch Support Device in Assisting Activities of Daily Living: A Pilot Study

T. Matsuda, K. Kakegawa, T. Watanabe, J. Ogawa, Y. Yamaguchi, S. Shimoda (Bunkyo-ku, Tokyo, Japan)
Effectiveness of Opicapone Added to Different Levodopa Doses and LEDDs in Parkinson’s Disease: Post-Hoc Analysis of the ADOPTION Trials

J. Ferreira, JY. Lee, HI. Ma, B. Jeon, W. Poewe, A. Antonini, F. Stocchi, D. Rodrigues, M. Fonseca, H. Brigas, J. Holenz, O. Rascol (Lisbon, Portugal)
Effectiveness of Tele-Education Programs in Improving Knowledge of Movement Disorders among Medical Students in Different Economic Settings

H. Elkasaby, F. Abdelbar, M. Badran, M. Mohamed, A. Nagah, Z. Hegazy, K. Ahmed, M. M.ELSAYED (Giza, Egypt)
Effectiveness, Safety, and Quality of Life Outcomes of Neurotoxin Injections in the Treatment of Essential Tremors: A Systematic Review

YJ. Rabe, A. Yu, JR. Yu, D. Simpson (San Juan City, Philippines)
Effects of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Motor Complications in Parkinson’s Disease

E. Tharp, J. Martinez-Lemus, C. Onuigbo, T. Thomas, C. Green, J. Suescun, T. Le, E. Rodarte, R. Ritter Iii, T. Ellmore, M. Schiess (New York, USA)
Effects of an Intensive Multidisciplinary Rehabilitation Program on Patients with Spinocerebellar Ataxia

F. Coimbra, MC. da Cunha, J. Veloso, M. da Cunha, MR. Moreno, E. Mosimann, L. Siciliani, JR. Junior, J. Caetano, CE. Del Rio, C. Couto (Rio de Janeiro, Brazil)
Effects of conventional and adaptive deep brain stimulation on systemic oxy-Inflammation in Parkinson’s Disease

N. Maiorana, S. Marceglia, S. Mrakic-Sposta, A. Vezzoli, M. Guidetti, F. Martinelli Boneschi, T. Bocci, S. Oliveri, P. Signorelli, R. Ferrucci, A. Priori (Milan, Italy)
Effects of Deep Brain Stimulation on Sleep Disturbances in Parkinson’s Disease: a 4-Year Follow-Up Study

M. Tsalta-Mladenov, V. Dimitrova, M. Moynov, S. Andonova, Y. Enchev (Varna, Bulgaria)
Effects of Dynamic Neuro-Cognitive Imagery on FOG in People with Parkinson’s Disease: a Randomized Clinical Trial

P. Silva, K. Honda, L. Santos, J. Garcia, B. Silva, M. Piemonte (Sao Paulo, Brazil)
Effects of Exogenous Melatonin on Sleep and Motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta-Analysis

M. Alghaniem, A. Abunamoos, F. Qtaishat, A. Rababah, M. Abu Hasna, Y. Aljazi, M. Mustafa, F. Alnajjar, T. Patel, N. Hamam (Amman, 11942, Jordan)
Effects of Low-Intensity Exercise on Motor and Non-Motor Symptoms in a 6-OHDA-Induced Rat Model of Parkinson’s Disease

SP. Tsao, YW. Chen, HY. Huang (Taipei, Taiwan)
Effects of Physiotherapy on Mood Disorders in Patients with MSA, PSP, and PD

ET. Schoenfeldt-Reichmann, V. Sidoroff, H. Moradi, G. Prigent, S. Sapienza, F. Jagusch, I. Tackenburg, M. Asalian, N. Hergenroeder-Lenzner, M. Giraitis, J-P. Ndayisaba, G. Goebel, K. Seppi, A. Ionescu, F. Krismer, J. Winkler, B. Eskofier, J. Klucken, K. Aminian, G. Wenning, H. Gassner, C. Raccagni, D. Benninger (Lausanne, Switzerland)
Effects of transcutaneous periodic vibratory stimulation on gait and balance function in Spinocerebellar degeneration -a pilot study

N. Togashi, S. Kubokawa, K. Minemura, K. Tateno, Y. Miyagi, A. Kawanami, K. Hasegawa (Sagamihara, Japan)
Effects of transmembrane protein 106B genetic variations on disease progression in Parkinson’s disease

Y. Fan, W. Zhao, X. Liang, Y. Sun, J. Wang (Shanghai, China)
Efficacy and Feasibility of Telemedicine-Based Dietary Intervention vs. Outpatient Supervision for Drug-Resistant Multiple System Atrophy in Postmenopausal Women During COVID-19

M. Sharma, S. Sinha (Pimpri, India)
Efficacy and outcomes of deep brain stimulation in elderly Parkinson’s disease: An institutional based study

M. Karri, R. Kandadai, R. Borgohain, S. Kola, R. Alugolu, P. Vvsrk, T. Syed, S. Mohareer, Y. Kancharla (Hyderabad, India)
Efficacy and Safety of Deutetrabenazine in Huntington’s Disease: a Systematic Review

A. Viapiana, V. Müller, L. Lima, A. Petry, R. Juvêncio, A. Ribeiro, D. Gonçalves, M. da Rosa, G. Maia, V. Xavier (Porto Alegre, Brazil)
Efficacy and Safety of Different Apomorphine Formulations for OFF Episodes in Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Abunamoos, M. Alghaniem, Y. Aljazi, F. Alnajjar, A. Al-Qudah, Q. Abulawi, M. Mustafa (Amman, Jordan)
Efficacy and Safety of Dual-Target Transcranial Magnetic Stimulation in Essential Tremor: A Phase 2 Randomized, Controlled, Patient-Assessor blinded Trial

J. Xu, N. Cao, Y. Qu, S. Shang, X. Bai, X. Liu, X. Liu, X. Wang, F. Hu, Q. Qu, M. Zhang, H. Cao (Xi’an, China)
Efficacy and Safety of Ecopipam for Tourette Syndrome (TS): Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

K. Tomczak, S. Atkinson, D. Kim, M. Miller, P. Rice, G. Karkanias, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Chicago, USA)
Efficacy And Safety of Fecal Microbiota Transplant for Parkinson’s Disease: A Systematic Review And Meta-Analysis

A. Koppanatham, A. Bin Gulzar, M. Ammar Arshad, E. de Farias, V. Suresh, M. Tariq, R. Vasireddy, T. Varkey (Lahore, Pakistan)
Efficacy and Safety of Fecal Microbiota Transplantation in the Management of Parkinson’s Disease: A Systematic Review

Y. Abdalla, A. Hassan (Zagazig, Egypt)
Efficacy and Safety of IPX203 and Levodopa-Carbidopa Intestinal Gel (LCIG) Compared to Immediate-Release Carbidopa-Levodopa in Parkinson’s Disease: A Systematic Review and Meta-Analysis

M. Mustafa, A. Abunamoos, Y. Aljazi, F. Alnajjar, A. Sa’D, M. Alghaniem, K. Abuhananeh (Amman, Jordan)
Efficacy and Safety of Nicotine in Parkinson’s Disease: A Systematic Review and Meta-analysis

O. Razouk, A. Ahmad, K. Mustafa, A. Habib, A. Al Midani (Sharjah, United Arab Emirates)
Efficacy and safety of Rotigotine Extended-Release Microspheres in Early Parkinson’s Disease

H. Sun, X. Dan, H. Chen, J. Feng, W. Wang, Q. Ye, Y. Liu, C. Liu, S. Chen, P. Chan (Beijing, China)
Efficacy and Safety of Transcutaneous Auricular Vagal Stimulation on Gait in Patients with Parkinson’s Disease: a Systematic Review

K. Silva, L. Cabral, M. Kozlowski, W. Damasio (São José dos Campos, Brazil)
Efficacy of adhering to a Ketogenic Diet in Parkinson’s Disease: a Systematic Review and Meta-Analysis

G. Guindani Maia, V. Ritt Xavier, V. Serafim, M. Neto, L. Nardi Motta, V. Müller, I. Alicia Fink, AC. Sgarioni Viapiana, MF. Peruci Felippe, L. Bedatti Koehler, C. Rieder (Porto Alegre, Brazil)
Efficacy of Clonidine for Tourette Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials

Y. Aljazi, A. Abunamoos, F. Alnajjar, M. Mustafa, J. Al-Tarawneh, L. Aldaher, M. Alghaniem (Amman, Jordan)
Efficacy of Combined Transcranial Direct Current Stimulation (tDCS) and Gait Training on Gait in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

A. Hegazi, H. Hussein, R. Mohamed (Mansoura, Egypt)
Efficacy of LSVT-BIG Treatment Compared to Other Physiotherapy in Patients with Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

A. Amin, M. Helal, A. Alsokery, H. Sabet, A. Ibrahim, A. Suleiman, I. Yakout, A. Abunamoos, M. Elsayed (Cairo, Egypt)
Efficacy of ND0612 in Patients at Different Stages of Disease Severity: Subgroup-Analyses From a Randomized, Active-Controlled Study in People With Parkinson’s Disease Experiencing Motor Fluctuations

H. Sarva, R. Dhall, L. Lopez-Manzanares, J. Kulisevsky, N. Lopes, J. Pereira, S. Isaacson (New York, USA)
Efficacy of Rifaximin as an Adjunct Treatment for Levodopa induced dyskinesia: Preliminary Results

K. Salinas-Barboza, J. Altamirano, L. Navarro-Roa, M. Rodriguez-Violante (Ciudad de México, Mexico)
Efficacy of Stimulant Use for Cognitive Fluctuations in Lewy Body Dementia: A Case Study

L. Lopez, A. Petrov, Z. Afshari (Glenview, USA)
Efficacy of Unilateral Focused Ultrasound Subthalamotomy in Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Ahmad, A. Al Midani, O. Razouk, S. Al Shaikhli, A. Khater, M. Al Khalidi (Sharjah, United Arab Emirates)
Efficacy of Ventral Intermediate Nucleus Deep Brain Stimulation for Head Tremors in Essential Tremor: A Single-Center Retrospective Analysis

S. Anis, M. Munyeshyaka, J. Hsu, N. Mandava, C. Piccinin, R. Rammo, S. Nagel, H. Fernandez (Cleveland, USA)
Eight-Year Outcome of Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease Patients

I. Schlesinger, M. Nassar, A. Sinai, I. Senderova, M. Katson, M. Constantinescu, M. Zaaroor, L. Lev Tov (Haifa, Israel)
EJS ACT-PD: An Ongoing Initiative to Support Innovation and Sustainability of a Multi-Arm, Multi-Stage Platform Trial for Parkinson’s Disease

G. Mills, C. Gonzalez-Robles, M-L. Zeissler, O. Bandmann, R. Barker, J. Carpenter, S. Collins, J. Duffen, S. Gandhi, K. Mcfarthing, A. Schapira, A. Schrag, C. Carroll, T. Foltynie (London, United Kingdom)
Electrochemical Sensing for Accurate L-Dopa Detection in Parkinson’s disease

P. Dutta, A. Eshore, P. Guha, M. Acharya (Kharagpur, India)
Electrophysiological Mapping in Asleep vs. Awake DBS

P. Kahali, R. Jamiolkowski, B. Reid, M. Willsey, M. Nuese, R. Fanning, V. Buch, M. Ferris (Palo Alto, USA)
Electrophysiology in Distinguishing Functional Tremor from Organic Tremor: A Systematic Review and Meta-Analysis of Diagnostic Accuracy

S. Rujirussawarawong, C. Ounmuang, S. Aungsumart, C. Kasemsuk, N. Limotai (Bangkok, Thailand)
Elevated Risk of Dementia with Lewy Bodies subsequent to Military Trauma

E. Blake, S. Karki, J. Quinn, G. Scott, L. Neilson (Portland, USA)
Elucidating Tau and Alpha-synuclein Co-pathology in RAB39b X-linked Parkinson’s Disease.

M. Kim, A. Park, E. Chiu, J. Weiss, S. Yu, D. Yearout, C. Zabetian, O. Betancour, M. Davis (Seattle, USA)
Embodying a Sixth Soft Finger. How Wearing a Supernumerary Robotic Digit Impacts our Body Schema

J. Sykes, F. Genovese, G. Barchiesi, C. Sinigaglia (Milan, Italy)
Empathy in Action A Sensory Experience for Healthcare Providers

K. Papesh, A. Mitchell, C. Pizzillo (Phoenix, USA)
End-of-life care management in Parkinson’s disease: a national survey of caregivers’s own experiences and perceptions

A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)
End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)
Engage- Qatar PD: The development of an online self-management intervention to promote engagement in physical activity for people with PD in Qatar

H. Khalil, R. Hammad, M. Rawash, S. Pedersen, L. Morris, M. Choudhury, L. Quinn, A. Oun (Doha, Qatar)
Enhancing Parkinson’s Disease Detection Through Chemical and Motor Biomarkers

C. Marshall, M. Kling, L. Linch, N. Hashemi, E. Stegemoller (Ames, USA)
Enhancing Parkinson’s Nurse Care with AI-Driven Remote Symptom Monitoring

F. Chmell, P. Lee, M. Sander (München, Germany)
Enhancing Safety and Quality of Care for Parkinson’s Disease Patients Hospitalized at a Large Academic Medical Center

C. Kim, C. Malatt, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)
Enhancing Sleep in Parkinson’s Disease: A Retrospective Study on Group CBT-I

N. Hellmers, A. Weiss, D. Zhang, P. Glovinsky, D. Barone, A. Yoo, H. Ooi, H. Sarva (New York, USA)
Enhancing Step Detection in Real-World Gait

A. Ena, C. Mazzà, E. Bartholomé, C. Bernasconi, S. Belachew, ó. Reyes (Basel, Switzerland)
Enhancing the differential diagnosis of atypical parkinsonian syndromes through a structured clinical acrostic

L. Ortega-Bolaños, V. Martinez-Villota, G. Pinilla-Monsalve, E. Gatto (Cali, Colombia)
Enhancing Usability of PRIMS: A Video-Based Automated Parkinson’s Motor Assessment Informed by User Feedback

B. Bridges, R. Singh, M. Squires, J. Weber, A. Podlewska (St John's, Canada)
Enrolling iRBD Participants in the Parkinson’s Progression Marker Initiative (PPMI) – Facilitating Collaboration between Movement Disorders and Sleep Clinics

J. Ricci, K. Marek, B. Mcmahon, T. Simuni, A. Videnovic, K. Chou, C. Marras, T. Mestre, C. Bae, N. Dahodwala, D. Galasko, A. Amara, D. Standaert, C. Tanner, R. Zuzuarregui, H. Attarian, A. Espay, M. Fullard, H. Fernandez, G. Riboldi, D. Shprecher, M. Muntean, S. Schade, B. Mollenhauer, E. Tolosa, M. Marti, A. Garrido, L. Stefanis, C. Koros, M. Breg, N. Pavese, D. Ledingham, K. Anderson, M. Hu, W. Oertel, A. Janzen, S. Bressman, E. During, A. Noyce, C. Simonet, L. Perez-Carbonell (New Haven, USA)
Enrollment Challenges and Strategies in Early-Stage Parkinson’s Disease Clinical Trials: Comparing Treatment-Naïve and Previously Treated Patient Populations

J. Roberts, A. Lysandropoulos (Durham, USA)
Epidemiology of Parkinson’s disease in Southern Brazil: Age- and Sex-Specific Findings from the PROBE-PD Study

G. Pereira, N. Soares, C. Sangali, D. Teixeira-Dos-Santos, G. Valença, B. Lopes, P. Brandão, C. Rieder, A. Schuh (Porto Alegre, Brazil)
Epigenome-wide and gene-targeted epigenetic profile of isolated REM Sleep Behaviour Disorder: a clinico-molecular study

L. Baldelli, C. Pirazzini, L. Sambati, F. Ravaioli, F. Di Laudo, D. Gentilini, P. Guaraldi, C. Franceschi, P. Cortelli, P. Garagnani, G. Calandra-Buonaura, MG. Bacalini, F. Provini (Bologna, Italy)
Episodic Generalized Dystonia with Opisthotonus Posturing in Early Stages of Anoxic Brain Injury with Mild Degrees of Caudate Involvement

S. Ghourchian, M. Mizrahi, D. Lerner, DM. Magurno (Brooklyn, USA)
Episodic Rocking Movements in a Young Boy.

A. Singh, J. Singhvi, D. Das, I. Goel (Mohali, India)
Episodic Simulation in Parkinson’s Disease (PD)

J. Decker, N. Hantke, E. Leonard (Portland, USA)
Equity in Access to MRI-Guided Focused Ultrasound for Movement Disorders: Patient Characteristics and Treatment Disposition

M. Park, D. Gonzalez, N. Pertsch, K. Sakakura, C. Swan, M. Wodziak, D. Ulrich, A. Karstens (Chicago, USA)
Essential Tremor Prevalence in Northeast-Central Pennsylvania

D. Kratovil, S. Jung, D. Rompivalasa, S. Stoica, A. Stanciu, M. Sandulescu (Danville, USA)
Establishing a Timeline of Non-Motor and Motor Symptoms Progression in Parkinson’s Disease Using a Sub-Chronic MPTP Mouse Model

M. Chopra, A. Sekar, R. Hussain, L. Diwakar (Bengaluru, India)
Establishing and Leveraging a Community Advisory Board to Guide Study Design, Speed Recruitment and Encourage Retention

C. Destro, M. Kuhl, C. Kelliher, R. Dobkin, S. Mantri, T. Tropea, A. Matthews, J. Carley, E. Flagg, W. Kutler (New York, USA)
Establishing Clinical Education and Patient Support Programs for Continuous Subcutaneous Apomorphine Infusion (CSAI) in the United States

N. Crouse, C. Happel, M. Grall (Rockville, USA)
Ethnicity in Parkinson’s Disease: A Brazilian Cross-sectional Study

J. Oliveira, G. Nunes, N. Dos Santos, F. Brito, J. Costa, E. Muricy, G. de Vasconcelos, S. Baran, R. Kauark (Salvador, Brazil)
European Experience with Long-term Continuous Subcutaneous Apomorphine Infusions at Higher Doses

M. Grall, J. Parsons, A. de Groot, A. Sesar, P. Qin, M. Vérin (Rockville, USA)
European-Derived Parkinson’s Disease Polygenic Risk Score Model Is Associated With PD Status, UPDRS Score But Not Age At Onset Or Cognitive Impairment In An Egyptian PD Dataset

S. El-Shafie, A. Nagano, I. Elsayed, E. Khedr, M. William, A. El-Hosseiny, A. Shalash, G. Fawi, M. Yousef, S. El-Jaafary, H. Lee, A. Jama, M. Koraym, Y. Salah, A. Atputhavadivel, S. Elfarrash, Y. Elsaid, A. Gabr, N. Shebl, L. Aly, N. Abdelwahhab, T. Belal, N. Elsayed, M. El-Gamal, S. Elgamal, S. Ragab, J. Mekky, H. Houlden, M. Salama, M. Rizig (Cairo, Egypt)
Evaluating Inter-rater Variability in UPDRS Using IMU: A Comparison Between Beginner and Experienced Specialists

TC. Fang, PS. Lu, YJ. Guo, JA. Huang, LW. Ko (Taichung, Taiwan)
Evaluating the Efficacy of Home-Based Exercise Interventions for Individuals with Mild to Moderate Parkinson’s Disease: A Systematic Review

M. M. Elsayed, M. Alomari, N. Abdeltawab, O. Hafez, N. Elmestkawy, M. Mustafa, A. Abdelsalhin, S. A. Hassan (Mansoura, Egypt)
Evaluating the Efficacy of Virtual Reality Simulations in Enhancing Balance Recovery Among Older Adults: A Systematic Review Using Statistical Modeling

M. Ali, N. Bekhit, F. Sakr, A. Hafez, M. Mohamed, O. Awadalla, A. Nagah, M. M. Elsayed (Mansoura, Egypt)
Evaluating the Impact of Advocacy Efforts in Integrating Parkinson’s Disease into the Ethiopian Primary Healthcare System: Lessons from Parkinson’s Patients Support Organization Ethiopia (PPSO-E)

Z. Bayu (Addis Ababa, Ethiopia)
Evaluation of Changes in Non-Motor Symptoms in Parkinson’s Disease Patients: A Twelve-Month Follow-Up After Bilateral Deep Brain Stimulation in the Subthalamic Nucleus

R. Cong Torres, C. Martínez Cortés, J. Hernández Domínguez, JC. Hernández Rivera, C. Zúñiga Ramírez (Mexico City, Mexico)
Evaluation Of Diagnostic Latency In Parkinson’s Disease Based On Non-Motor Symptoms Subtype

D. Ulloa-Hernández, A. Hernández-Medrano, A. Cervantes-Arriaga, E. Ramírez-Benitez, M. Velasco-Delgado, G. Martin-Mafud, M. Rodríguez-Violante (Mexico City, Mexico)
Evaluation of Effects of Levodopa and Subthalamic Nucleus Stimulation (STN-DBS) on Gait using Quantified Timed Up and Go Test in People with Parkinson’s Disease (PD)

F. Ruggieri, E. Reynolds, C. O'Keeffe, J. Inocentes, M. Kelly, E. Donlon, M. Garvey, N. Austin, C. Fearon, C. Moran, R. Walsh (Dublin, Ireland)
Evaluation of Impact of Helicobacter Pylori Eradication on Symptomatology and Quality of Life in Parkinson’s Disease

A. Kakkar, G. Vishwas, S. Mehta, S. Pattanaik, S. Bhattacharyya, V. Sharma, M. Modi (Chandigarh, India)
Evaluation of Local Field Potential-guided DBS-programming in a Parkinson’s disease outpatient clinic

V. Zentsch, N. Warneke, I. Aymanns, D. Putzer, T. Huchtemann, T. Warnecke, I. Claus (Muenster, Germany)
Evaluation of Neuroprotective Effect of Terminalia macroptera on Rotenone Induced Parkinson’s Disease in Mice

L. Ior, E. Ishaya, P. Ezeuduji (Jos, Nigeria)
Evaluation of Nociception in a Model of Parkinson’s Disease for the Study of Non-Motor Symptoms in Trpv4-/- Animals

L. Pereira, K. Viero, G. Trevisan, C. Antoniazzi (Santa Maria, Brazil)
Evaluation of Perfusion, Iron Deposition, and Neuromelanin MRI Biomarkers Following Mesenchymal Stem Cell Treatment in a Phase 2 Parkinson’s Disease Trial

J. Martinez-Lemus, E. Tharp, T. Ellmore, T. Thomas, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte-Rascon, R. Ritter Iii, M. Schiess (Houston, USA)
Evaluation of swallow tail sign on 1.5 Tesla Magnetic Resonance Imaging in Parkinson´s disease patients in a tertiary hospital

E. Vioncek, M. Ferreira Cordellini, L. Kami, B. Teixeira (Curitiba, Brazil)
Evaluation of the Pharmacodynamic Effects of BIIB122/DNL151 in Participants with LRRK2 mutation-driven Parkinson’s disease (BEACON Study)

J. Kluss, S. Huntwork-Rodriguez, D. Jennings, S. Ota, R. Maciuca, J. Alkabsh, S. Davis, J. Suh, M. Schwarzschild, K. Fraser, R. Llorens-Arenas, C. Ho, P. Chin (South San Francisco, USA)
Evaluation Of Visual Perception Using Noise Pareidolia Test in Bangladeshi Patients with Parkinson’s disease.

T. Zannat, E. Camboe, K. Dey, A. Zirra, A. Haque, D. Mair, S. Waters, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh)
Evoked Resonant Neural Activity localises STN DBS programs more ventrally than clinician and imaging-guided methods in Parkinson’s disease

K. Nagao, T. Perera, M. Petoe, W-L. Lee, H. Mcdermott, K. Bulluss, W. Thevathasan (East Melbourne, Australia)
Examining Disparities and Device Usage in Outpatient Telemedicine Visits Amongst Movement Disorders Patients

V. Palakuzhy, B. Ouyang, G. Stebbins, C. Goetz, M. Afshari (Chicago, USA)
Examining the Gut Microbiome in Parkinson Patients with GBA Mutations

H. Dainton-Howard, A. Keshavarzian, A. Kirby, C. Goetz (Chicago, USA)
Examining the Impact of a Single Session of Myofascial Release via Dry Needling on Step Length in Individuals with Parkinson’s Disease

A. Tahara, A. Gastaldi, A. Chinaglia, V. Tumas, P. Santiago (Ribeirão Preto, Brazil)
Examining the Influence of Task Complexity on Dual Task Performance in Parkinson’s disease.

S. Conklin, P. Hill, L. Schwarz, YF. Chiu, J. Longhurst (Saint Louis, USA)
Excitatory/inhibitory Balance Differences Suggests Distinct Pathophysiology Between Blepharospasm and Cervical Dystonia

C. Dintino, N. Mukhopadhyay, C. Groth, B. Berman (Richmond, USA)
Exome-wide Burden Analysis Identifies SYT10 as a Genetic Modifier of GBA-PD in UK Biobank

J. Kim, J. Shulman (Houston, USA)
Expanding the Clinical Spectrum of Fejerman Syndrome: Insights from Video EEG and Long-Term Follow-Up

M. Hull, M. Sudheendra, M. Gonzalez, B. Evans, D. Takacs, A. Katyayan (Houston, USA)
Expanding the Geographic Spectrum of Guam Complex: A Case Report from Colombia

A. Alonso, L. Granados, A. Ferreiros (Bogotá, Colombia)
Expanding the Phenotypic Spectrum of CACNA1A Variants: A Single-Center Experience

H. Alfaris, S. Yoganathan, P. Jain, M. Moharir, G. Costain, V. Chau, C. Gorodetsky (Toronto, Canada)
Expanding the Scope Beyond Neurosurgery: A Systematic Review on MRgFUS Complications

K. Heintzelman, D. Fletcher, J. Melott, K. Gelman, B. Mendelson, A. Memon (Morgantown, USA)
Expanding the Spectrum of Alzheimer’s Disease Clinical Presentations: Progressive Dysarthria with Monomelic Tremor

O. Carranza-Renteria, G. Gliebus (Boca Raton, USA)
Exploratory Longitudinal Analysis of Lifestyle and Parkinson’s Disease Symptoms

N. Meier, O. Di Martino, I. Chaturvedi (Irvine, USA)
Exploring Cardiac Autonomic Dysfunction in Synucleinopathies with Parkinsonism Across Awake-Sleep Stages

N. Limotai, T. Somboon, S. Rujirussawarawong, T. Tumnark, N. Suanprasert, N. Unwanatham, C. Limotai (Bangkok, Thailand)
Exploring Clinical and Neurophysiologic Predictors of Adaptive Deep Brain Stimulation Response in Parkinson’s disease

T. Herrington, M. Beudel, J. Ostrem, S. Little, A. Ramirez-Zamora, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, L. Tonder, Y. Tan, R. Summers, S. Stanslaski, H. Bronte-Stewart (San Francisco, USA)
Exploring Deep Learning-Based Facial Analysis for Detecting Parkinsonism

M. Kameyama, Y. Umeda-Kameyama, H. Umegaki, R. Sengoku, K. Iijima, T. Matsubara, Y. Osakada, Y. Izumi (Tokyo, Japan)
Exploring Dysgeusia after cZI-DBS Implantation for Tremor Control: Insights from a Case series

R. Vasireddy, F. Sturgill, J. Gurwell, C. van Horne (Lexington, USA)
Exploring expectation bias in Parkinson’s disease clinical trials by comparing placebo arm progression on MDS-UPDRS to a natural history dataset

M. Potashman, L. Powell, B. Rogula, F. Nagase, C. de Brun, V. Coric, J. Dubow, L. Rosenthal, G. L'Italien (New Haven, USA)
Exploring local gyrification index to understand Parkinson’s disease with mild cognitive impairment

N. Chaurasiya, A. Katragadda, G. Rathi, J. Caldwell, Z. Mari, V. Mishra (Birmingham, USA)
Exploring minzasolmin effect on digital measures captured by the Verily Study Watch in a subset of the ORCHESTRA trial participants

B. Bloem, V. Hinson, E. Goikoetxea, L. Gaetano, K. Ray, F. Ambrosetti, KC. Ho, M. Key Prato, A. Pethe, V. Ticcinelli, J. Trzebinski, S. Warma, A. Khanna, Z. Ali (Nijmegen, Netherlands)
Exploring Neuroprotective Role of Natural Compound by Targeting c-Abl Kinase in Parkinson’s Disease

D. Khatri (Chandwaji, Jaipur, India)
Exploring pallidal gamma oscillations in Parkinson’s disease: A case report

H. Kamo, J. Cagle, K. Johnson, M. Eisel, J. Wong, C. Hemptinne (Gainesvile, USA)
Exploring Pallidothalamotractotomy as an Option for Management of Refractory Dystonia following Failure of Pallidotomy

A. Adhya, D. Garg, D. Radhakrishnan, A. Das, E. Arun, R. Rajan, A. Garg, A. Srivastava, K. Garg (New Delhi, India)
Exploring sexuality, intimacy and relationship changes in people with Parkinson’s Disease and their partners; What do they want to know and how can we help?

A. Terrens, A. Lewis, S. Soh, P. Morgan, J. Mcginley (Wantirna, Australia)
Exploring the Association between Autonomic Responses and Dopaminergic Pathways in Early Parkinson’s Disease

E. Garasto, A. Stefani, M. Pierantozzi, N. Mercuri, A. Chiaravalloti, C. Rocchi (Rome, Italy)
Exploring the Association Between Interoceptive Awareness and Neuropsychiatric Symptoms in People Living with Parkinson’s Disease

MF. Medina Pérez, AJ. Hernández Medrano, A. Cervantes Arriaga, M. Rodriguez Violante (Mexico, Mexico)
Exploring the Association of APOE Polymorphism and the Clinical Course of CSF1R-Related Disorder

A. Strongosky, T. Chmiela, M. Baker, Z. Wszolek (Jacksonville, USA)
Exploring the Characteristic Features of Speech and Facial Expressions in Patients with Huntington’s Disease Based on Machine Learning

L. Lu, J. Yin, N. Yan, Y. Huang (Sydney, Australia)
Exploring The Correlation of Neuroimaging, Molecular and Electrophysiological Biomarkers in Patients with Progressive Supranuclear Palsy – Richardson Type

S. Mondal, B. Biswas, R. Banerjee, S. Choudhury, K. Chatterjee, J. Rungta, S. Sengupta, A. Bayen, P. Basu, E. Basu, S. Dasgupta, G. Ahmed, J. Ganguly, M. Tiwari, H. Kumar (Kolkata, India)
Exploring the Impact of Delayed Neural Feedback on Motor Performance: A Meta-Analysis of Robotic Balance Training Interventions

M. Elsayed, A. Abdelsalhin, M. Mustafa, N. Elmestkawy, O. Hafez, N. Abdeltawab, M. Alomari, M. M. Elsayed (Mansoura, Egypt)
Exploring the Neuroprotective Potential of Raloxifene and Fulvestrant Against Haloperidol Induced Parkinson Disease; Insights into GPR30/PI3k/Akt/Nrf2 Signaling Pathways

S. Upadhayay, P. Kumar (BATHINDA, India)
Exploring the Relationship Between Pesticides and Parkinson’s Disease in El Salvador

S. Peña Martínez, T. Ascencio, P. Salles, I. Mata (San Salvador, El Salvador)
Exploring the Role of Aperiodic and Periodic Spectral Activity in Guiding Deep Brain Stimulation Electrode Selection for Childhood Dystonia

T. Larsh, S. Vadivelu, J. Skoch, T. Lipps, D. Gilbert, S. Wu (Cincinnati, USA)
Exploring the Trade-offs Between Speech and Gait in Parkinson’s Disease

YF. Chiu, J. Longhurst, A. Fletcher, T. Loux (Saint Louis, USA)
Exploring the ubiquitome in Parkinson’s Disease

A. Yeung, SA. Cobbold, M. Li, GK. Smyth, L. Wang, JR. Han, IKL. Tan, M. Bahlo, AH. Evans, D. Komander, S. Masaldan, G. Dewson (Melbourne, Australia)
Exploring Uncertainties and Fears of People with Parkinson Disease

P. Gandhi, E. Trahair, D. Steiger, R. Rapoport, L. Chahine, C. Marras, S. Mantri (Edmonton, Canada)
Exploring Visual Scanning Behavior and Novelty Seeking in Parkinson’s Disease: A Pilot Study

K. Paulk, H. Ferguson, L. Neilson, N. Hantke (New Orleans, USA)
Extracorporeal Shockwave Therapy (ESWT) for Neck Pain and Shoulder-Scapular Dyskinesis: An Objective Evaluation Study

L. Kalika, R. Bubnov (Kyiv, Ukraine)
Eye movement abnormalities in GBA1-related Parkinson’s disease and non-manifesting GBA1-carriers

G. Riboldi, T. Hudson, H. Conn, K. Astudillo, J. Rizzo, S. Frucht, J. Rucker (New York, USA)
Eye tracking identifies biomarkers predicting Parkinson’s disease before motor symptom onset

A. Yoritaka, M. Ando, S. Nakayama, K. Fusegi, S. Nojiri, A. Tozuka, Y. Wang, W. Urasaki, N. Hattori (Saitama, Japan)